[1]Jasmer RM, Nahid P, Hopewell PC. Latent tuberculosis infection[J]. N Engl J Med, 2002, 347(23):1860-1866. [2]中华人民共和国卫生部. 2000年全国结核病流行病学抽样调查报告[J].中国防痨杂志,2002, 24(2):65-108. [3]Lee E, Holzman RS. Evolution and current use of the tuberculin test[J]. Clin Infect Dis,2002, 34(3):365-370. [4]Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis[J]. Lancet,2000, 356(9235):1099-1104. [5]Richeldi L. An update on the diagnosis of tuberculosis infection[J]. Am J Respir Crit Care Med, 2006, 174(7):736-742. [6]Boom WH, Canaday DH, Fulton SA,et al. Human immunity to M. tuberculosis: T cell subsets and antigen processing[J]. Tuberculosis (Edinb), 2003, 83(1-3):98-106. [7]Fritsch RD, Shen X, Sims GP, et al. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27[J]. J Immunol,2005, 175(10):6489-6497. [8]Beverley PC. Primer: making sense of T-cell memory[J]. Nat Clin Pract Rheumatol, 2008, 4(1):43-49. [9]Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design[J].Nat Rev Immunol, 2008, 8(4):247-258. [10]Small PM, Fujiwara PI. Management of tuberculosis in the United States[J]. N Engl J Med,2001, 345(3):189-200. [11]Behr MA, Wilson MA, Gill WP,et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray[J]. Science, 1999, 284(5419):1520-1523. [12]Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy[J]. Chest, 2007, 131(6):1898-1906. [13]Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update[J]. Ann Intern Med, 2008, 149(3):177-184. [14]Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells[J].AIDS, 2002, 16(17):2285-2293. [15]Liebeschuetz S, Bamber S, Ewer K, et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study[J]. Lancet, 2004, 364(9452):2196-2203. [16]Nicol MP, Davies MA, Wood K,et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting[J]. Pediatrics,2009, 123(1):38-43. [17]Ferrara G, Losi M, D’Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study[J]. Lancet, 2006, 367(9519):1328-1334. [18]Lee JY, Choi HJ, Park IN, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection[J]. Eur Respir J, 2006, 28(1):24-30. [19]Kim SH, Choi SJ, Kim HB, et al. Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis[J]. Arch Intern Med, 2007,167(20):2255-2259. [20]Andersen P, Doherty TM, Pai M, The prognosis of latent tuberculosis: can disease be predicted [J]? Trends Mol Med, 2007, 13(5):175-182. [21]Janssens JP, Roux-Lombard P, Perneger T, et al. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis[J]. Eur Respir J, 2007, 30(4):722-728. [22]Chee CB, Barkham TM, Khinmar KW,et al. Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis[J]. Eur J Clin Microbiol Infect Dis,2009, 28(6):667-670. [23]Brodie D, Lederer DJ, Gallardo JS,et al. Use of an interferon-gamma release assay to diagnose latent tuberculosis infection in foreign-born patients[J]. Chest, 2008, 133(4):869-874. [24]Hesseling AC, Mandalakas AM, Kirchner LH,et al. Highly discordant T-cell responses in individuals with recent household tuberculosis exposure[J]. Thorax, 2008[Epub ahead of print] [25]Bakir M, Millington KA, Soysal A,et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact[J]. Ann Intern Med, 2008, 149(11):777-787. [26]Pathan AA, Wilkinson KA, Klenerman P, et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment[J]. J Immunol, 2001, 167(9):5217-5225. [27]Aiken AM, Hill PC, Fox A, et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases[J]. BMC Infect Dis, 2006, 6:66. [28]Breen RA, Hardy GA, Perrin FM,et al. Rapid diagnosis of smear-negative tuberculosis using immunology and microbiology with induced sputum in HIV-infected and uninfected individuals[J]. PLoS ONE, 2007, 2(12):e1335. [29]Strassburg A, Jafari C, Ernst M,et al.Rapid diagnosis of pulmonary TB by BAL enzyme-linked immunospot assay in an immunocompromised host[J]. Eur Respir J, 2008, 31(5):1132-1135.
|